85 related articles for article (PubMed ID: 22661441)
1. Handling S/MAR vectors.
Hagedorn C; Baiker A; Postberg J; Ehrhardt A; Lipps HJ
Cold Spring Harb Protoc; 2012 Jun; 2012(6):657-63. PubMed ID: 22661441
[TBL] [Abstract][Full Text] [Related]
2. A colony-forming assay for determining the establishment efficiency of S/MAR-containing nonviral episomal expression vectors.
Hagedorn C; Baiker A; Postberg J; Ehrhardt A; Lipps HJ
Cold Spring Harb Protoc; 2012 Jun; 2012(6):706-8. PubMed ID: 22661431
[TBL] [Abstract][Full Text] [Related]
3. Scaffold/matrix attached region-based nonviral episomal vectors.
Hagedorn C; Wong SP; Harbottle R; Lipps HJ
Hum Gene Ther; 2011 Aug; 22(8):915-23. PubMed ID: 21644838
[TBL] [Abstract][Full Text] [Related]
4. Physiological levels of HBB transgene expression from S/MAR element-based replicating episomal vectors.
Sgourou A; Routledge S; Spathas D; Athanassiadou A; Antoniou MN
J Biotechnol; 2009 Aug; 143(2):85-94. PubMed ID: 19559736
[TBL] [Abstract][Full Text] [Related]
5. Rescue of S/MAR-containing nonviral episomal expression vectors.
Hagedorn C; Baiker A; Postberg J; Ehrhardt A; Lipps HJ
Cold Spring Harb Protoc; 2012 Jun; 2012(6):709-11. PubMed ID: 22661432
[TBL] [Abstract][Full Text] [Related]
6. Minicircle performance depending on S/MAR-nuclear matrix interactions.
Broll S; Oumard A; Hahn K; Schambach A; Bode J
J Mol Biol; 2010 Feb; 395(5):950-65. PubMed ID: 20004666
[TBL] [Abstract][Full Text] [Related]
7. Non-viral S/MAR vectors replicate episomally in vivo when provided with a selective advantage.
Wong SP; Argyros O; Coutelle C; Harbottle RP
Gene Ther; 2011 Jan; 18(1):82-7. PubMed ID: 20739959
[TBL] [Abstract][Full Text] [Related]
8. Controlled removal of a nonviral episomal vector from transfected cells.
Rupprecht S; Hagedorn C; Seruggia D; Magnusson T; Wagner E; Ogris M; Lipps HJ
Gene; 2010 Oct; 466(1-2):36-42. PubMed ID: 20621169
[TBL] [Abstract][Full Text] [Related]
9. The functional role of S/MARs in episomal vectors as defined by the stress-induced destabilization profile of the vector sequences.
Giannakopoulos A; Stavrou EF; Zarkadis I; Zoumbos N; Thrasher AJ; Athanassiadou A
J Mol Biol; 2009 Apr; 387(5):1239-49. PubMed ID: 19248788
[TBL] [Abstract][Full Text] [Related]
10. Gene transfer into human hematopoietic progenitor cells with an episomal vector carrying an S/MAR element.
Papapetrou EP; Ziros PG; Micheva ID; Zoumbos NC; Athanassiadou A
Gene Ther; 2006 Jan; 13(1):40-51. PubMed ID: 16094410
[TBL] [Abstract][Full Text] [Related]
11. Non-viral episomal modification of cells using S/MAR elements.
Argyros O; Wong SP; Harbottle RP
Expert Opin Biol Ther; 2011 Sep; 11(9):1177-91. PubMed ID: 21548848
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle dependent histone dynamics of an episomal non-viral vector.
Rupprecht S; Lipps HJ
Gene; 2009 Jun; 439(1-2):95-101. PubMed ID: 19306916
[TBL] [Abstract][Full Text] [Related]
13. Modified S/MAR episomal vectors for stably expressing fluorescent protein-tagged transgenes with small cell-to-cell fluctuations.
Mizutani A; Kikkawa E; Matsuno A; Shigenari A; Okinaga H; Murakami M; Ishida H; Tanaka M; Inoko H
Anal Biochem; 2013 Dec; 443(1):113-6. PubMed ID: 23969013
[TBL] [Abstract][Full Text] [Related]
14. Efficient episomal gene transfer to human hepatic cells using the pFAR4-S/MAR vector.
Giannakopoulos A; Quiviger M; Stavrou E; Verras M; Marie C; Scherman D; Athanassiadou A
Mol Biol Rep; 2019 Jun; 46(3):3203-3211. PubMed ID: 30980265
[TBL] [Abstract][Full Text] [Related]
15. New insights into stability of recombinant adenovirus vector genomes in mammalian cells.
Rauschhuber C; Noske N; Ehrhardt A
Eur J Cell Biol; 2012 Jan; 91(1):2-9. PubMed ID: 21440326
[TBL] [Abstract][Full Text] [Related]
16. Advances in the Development and the Applications of Nonviral, Episomal Vectors for Gene Therapy.
Mulia GE; Picanço-Castro V; Stavrou EF; Athanassiadou A; Figueiredo ML
Hum Gene Ther; 2021 Oct; 32(19-20):1076-1095. PubMed ID: 34348480
[TBL] [Abstract][Full Text] [Related]
17. Genetically modified pigs produced with a nonviral episomal vector.
Manzini S; Vargiolu A; Stehle IM; Bacci ML; Cerrito MG; Giovannoni R; Zannoni A; Bianco MR; Forni M; Donini P; Papa M; Lipps HJ; Lavitrano M
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17672-7. PubMed ID: 17101993
[TBL] [Abstract][Full Text] [Related]
18. MAR characteristic motifs mediate episomal vector in CHO cells.
Lin Y; Li Z; Wang T; Wang X; Wang L; Dong W; Jing C; Yang X
Gene; 2015 Apr; 559(2):137-43. PubMed ID: 25598284
[TBL] [Abstract][Full Text] [Related]
19. Safeguarding pluripotent stem cells for cell therapy with a non-viral, non-integrating episomal suicide construct.
Zhao Q; Lu B; George SK; Yoo JJ; Atala A
Biomaterials; 2012 Oct; 33(29):7261-71. PubMed ID: 22795541
[TBL] [Abstract][Full Text] [Related]
20. The production of foreign proteins in mammalian cells.
Bendig MM
Genet Eng; 1988; (7):91-127. PubMed ID: 3078408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
